SCHEMBL12814050

SCHEMBL12814050

OC(=S)c1ccccc1C1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGDR2 Q9Y5Y4 1/20 0.45
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ CYP2D6 P10635 1/20 0.37
▸ SLC6A2 P23975 1/20 0.37
▸ SLC6A4 P31645 1/20 0.37
▸ SLC6A3 Q01959 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ PTGS2 P35354 1/20 0.37
▸ HDAC3 O15379 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ ABCC1 P33527 1/20 0.36
▸ LMNA P02545 4/20 0.36
▸ GAA P10253 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KMO O15229 1/20 0.35
▸ NOS1 P29475 1/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ MAPK1 P28482 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28284352 0.98 PTGDR2 (0.42) PTGDR2MEN1KMT2ACYP2D6SLC6A2
SCHEMBL18091789 0.82 PTGDR2 (0.38) PTGDR2MEN1KMT2APTGS2ABCC1
Hydrogen Peroxide SCHEMBL3679819 0.81 PTGDR2 (0.55) PTGDR2MEN1KMT2APTGS2GAA
Hydrogen Peroxide SCHEMBL11398422 0.81 PTGDR2 (0.55) PTGDR2MEN1KMT2APTGS2GAA
SCHEMBL4880185 0.81 PTGDR2 (0.41) PTGDR2MEN1KMT2ACYP2D6SLC6A2
SCHEMBL50486 0.81 PTGDR2 (0.53) PTGDR2CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL30730923 0.81 PTGDR2 (0.53) PTGDR2CYP2D6SLC6A2SLC6A4SLC6A3
Ammonia Solution, Strong SCHEMBL29036685 0.79 PTGDR2 (0.51) PTGDR2CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL12814062 0.79 PTGDR2 (0.41) PTGDR2MEN1KMT2ACYP2D6SLC6A2
Benzene SCHEMBL27853973 0.79 PTGDR2 (0.52) PTGDR2MEN1KMT2APTGS2KMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2699606-B1 POLYMERS FUNCTIONALIZED WITH A CARBOXYLIC OR THIOCARBOXYLIC ESTER CONTAINING A SILYLATED AMINO GROUP BRIDGESTONE CORP (JP) 2016-09-28 — — EP claimed
EP-2699606-A2 POLYMERS FUNCTIONALIZED WITH A CARBOXYLIC OR THIOCARBOXYLIC ESTER CONTAINING A SILYLATED AMINO GROUP Bridgestone Corporation (JP) 2014-02-26 — — EP claimed
US-20140018500-A1 Polymers Functionalized With A Carboxylic Or Thiocarboxylic Ester Containing A Silylated Amino Group BRIDGESTONE CORPORATION (JP) 2014-01-16 — — US claimed
WO-2012135451-A2 POLYMERS FUNCTIONALIZED WITH A CARBOXYLIC OR THIOCARBOXYLIC ESTER CONTAINING A SILYLATED AMINO GROUP BRIDGESTONE CORPORATION (JP) 2012-10-04 — — WO claimed
CN-109476616-A Piperazinyl methanone NAAA inhibitor 加利福尼亚大学董事会 2019-03-15 — — CN disclosed
EP-2699606-B1 POLYMERS FUNCTIONALIZED WITH A CARBOXYLIC OR THIOCARBOXYLIC ESTER CONTAINING A SILYLATED AMINO GROUP BRIDGESTONE CORP (JP) 2016-09-28 — — EP disclosed
US-9403919-B2 Polymers functionalized with a carboxylic or thiocarboxylic ester containing a silylated amino group BRIDGESTONE CORPORATION (JP) 2016-08-02 — — US disclosed
EP-2699606-A2 POLYMERS FUNCTIONALIZED WITH A CARBOXYLIC OR THIOCARBOXYLIC ESTER CONTAINING A SILYLATED AMINO GROUP Bridgestone Corporation (JP) 2014-02-26 — — EP disclosed
US-20140018500-A1 Polymers Functionalized With A Carboxylic Or Thiocarboxylic Ester Containing A Silylated Amino Group BRIDGESTONE CORPORATION (JP) 2014-01-16 — — US disclosed
WO-2012135451-A2 POLYMERS FUNCTIONALIZED WITH A CARBOXYLIC OR THIOCARBOXYLIC ESTER CONTAINING A SILYLATED AMINO GROUP BRIDGESTONE CORPORATION (JP) 2012-10-04 — — WO disclosed
Send feedback